Led by Elaine M. Apperson MD, FAAP, the TrialNet team at Pediatric Endocrinology, Prisma Health—Upstate Children’s Hospital is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Pediatric Endocrinology, Prisma Health—Upstate Children’s Hospital is regionally overseen by University of Florida. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Christopher Kishiyama, MD, the TrialNet team at Providence Sacred Heart Medical Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Providence Sacred Heart Medical Center is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Associate Professor Tony Huynh, the TrialNet team at Queensland Children's Hospital is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Queensland Children's Hospital is regionally overseen by Walter and Eliza Hall Institute of Medical Research. If you reach out to TrialNet, you may be contacted by staff from either institution

Led by Jose Bernardo Quintos, MD, the TrialNet team at Rhode Island Hospital is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. 

Note: As a TrialNet affiliate, Rhode Island Hospital is regionally overseen by Yale University School of Medicine. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Riley Hospital for Children is one of eighteen Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Principal Investigator, Linda DiMeglio, MD, the TrialNet team at the Riley's is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Led by David Liljenquist, MD, the TrialNet team at Rocky Mountain Diabetes and Osteoporosis Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Rocky Mountain Diabetes and Osteoporosis Center is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Led by Rashmi Jain, MD., the TrialNet team at Sanford Children's Specialty Clinic is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Led by Luis Casas, MD, the TrialNet team at Sanford Health is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Sanford Health is regionally overseen by University of Minnesota. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Catherine Pihoker, MD, the TrialNet team at Seattle Children's Hospital is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Seattle Children's Hospital is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Daniel Flynn, MD, the TrialNet team at St. Lukes Humphreys Diabetes Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, St. Lukes Humphreys Diabetes Center is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution.